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Outcomes in Trials for Management of
Caries Lesions (OuTMaC): protocol
Falk Schwendicke1*, Thomas Lamont2 and Nicola Innes2
Abstract
Background: Clinical trials on caries lesion management use an abundance of outcomes, hampering comparison
or combination of different study results and their efficient translation into clinical practice. Core outcome sets are
an agreed standardized collection of outcomes which should be measured and reported in all trials for a specific
clinical area. We aim to develop a core outcome set for trials investigating management of caries lesions in primary
or permanent teeth conducted in primary or secondary care encompassing all stages of disease.
Methods: To identify existing outcomes, trials on prevention and trials on management of caries lesions will be
screened systematically in four databases. Screening, extraction and deduplication will be performed by two
researchers until consensus is reached. The definition of the core outcome set will by based on an e-Delhi
consensus process involving key stakeholders namely patients, dentists, clinical researchers, health economists,
statisticians, policy-makers and industry representatives. For the first stage of the Delphi process, a patient panel
and a separate panel consisting of researchers, clinicians, teachers, industry affiliated researchers, policy-makers, and
other interested parties will be held. An inclusive approach will be taken to involve panelists from a wide variety of
socio-economic and geographic backgrounds. Results from the first round will be summarized and fed back to
individuals for the second round, where panels will be combined and allowed to modify their scoring in light of
the full panel’s opinion. Necessity for a third round will be dependent on the outcome of the first two. Agreement
will be measured via defined consensus rules; up to a maximum of seven outcomes. If resources allow, we will
investigate features that influence decision making for different groups.
Discussion: By using an explicit, transparent and inclusive multi-step consensus process, the planned core outcome set
should be justifiable, relevant and comprehensive. The dissemination and application of this core outcome set should
improve clinical trials on managing caries lesions and allow comparison, synthesis and implementation of scientific data.
Trial registration: Registered 12 April 2015 at COMET (http://www.comet-initiative.org)
Keywords: Dental caries, Clinical trial, Delphi, Dental, Outcomes, Review
Background
Dental caries is one of the most commonly occurring
diseases worldwide [1]. It has significant impact on pa-
tients resulting from pain, infection, and loss of func-
tionality, and carries high lifelong costs from treating the
disease and its symptoms when prevention has failed.
Traditional curative dental care is the fourth most costly
disease to treat in most industrialized countries [2]. Car-
ies prevention has traditionally focused on non-operative
measures (plaque and diet control, fluoride application),
whilst caries treatment applies operative procedures,
traditionally involving removal of caries before placing a
restoration. However, recently, our understanding of the
disease caries, as a biofilm disorder, has evolved. This
understanding has led to novel non-operative and opera-
tive means for managing the disease or its symptoms.
However, there remains uncertainty as to which caries
management strategy is most suitable and under which
circumstances, leading to wasteful use of healthcare re-
sources and less-than-optimal outcomes. Part of this un-
certainty stems from the abundance of outcomes being
used in clinical trials, hampering comparison or combin-
ation of different study results [3, 4]. Consequently, trials
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on caries management are not efficient and their data
are not being maximized. Information on treatments’ ef-
fectiveness and efficacy are not well communicated
throughout the dental world, reducing the likelihood
that the highest standard of care is being delivered.
The COMET (Core Outcome Measures in Effective-
ness Trials) Initiative (http://www.comet-initiative.org)
provides a forum to bring together researchers interested
in the development, application and promotion of core
outcome sets (COS) that are defined as an agreed stan-
dardized collection of outcomes which should be mea-
sured and reported, as a minimum, in all trials for a
specific clinical area. Defining such COS involves sys-
tematically collecting existing outcomes, identifying
other outcomes that may not have been investigated,
categorizing them, ordering them according to agreed
needs and relevance, and eventually deciding on a COS
in consensus. This consensus process should ideally in-
volve patients, clinicians, researchers, teachers and any
other stakeholders [5]. Moreover, a COS should aim at
being as inclusive, i.e. applicable in different countries
and settings [6]. Developing a COS for management of
dental caries would encourage trialists to use outcomes
chosen by consensus that are relevant to patients and
clinicians and can be compared with similar studies.
Objectives
Our aim is to develop a COS for the management of
existing carious lesions in both primary and permanent
teeth using consensus across specialists in the area, pa-
tients and the public. The outcome set will be applicable
to studies investigating management of caries lesions in
primary or permanent teeth conducted in primary or
secondary care encompassing all stages of disease. It will
not be limited by health status, age or geographical loca-
tion of trials. The COS will be developed for manage-
ment of caries lesions including traditional preventive
measures such as fluoride varnish and fissure sealants
when they are used in the management of existing le-
sions. The primary goal of the interventions should be
to treat the lesion, even where the secondary goal in-
volves managing the pulp. The COS will not be applic-
able to treatments aimed directly at managing the dental
pulp, although other groups may develop core outcomes
for these fields and there may be overlap in the sets.
Methods/Design
Identifying existing knowledge
To identify all outcomes reported by randomized con-
trolled studies on prevention and treatment of caries le-
sions in primary and permanent teeth, two search
strategies will be developed; one for screening trials on
prevention of caries lesion development, the other for
management of caries lesions. Inclusion criteria will be
systematic reviews of RCTs, or RCTs, on preventing or
managing caries lesions. The reviews and trials will
either:
 compare an intervention for preventing or managing
the lesions to:
another prevention or management intervention or
no treatment; or
 compare interventions to support patients
undergoing dental procedures related to caries
No restrictions with regards to setting or location and
type of the prevented or treated lesion will be made.
Four electronic databases (Cochrane Central Register
of Controlled Trials, Cochrane Database of Systematic
Reviews, Medline via PubMed, Embase) will be searched
using defined strategies, and de-duplicated to provide a
single set of titles/abstracts. Titles and abstracts will be
screened by two calibrated reviewers for eligibility, and
consensus obtained by discussion or consulting a third
reviewer. Data from eligible studies will be independ-
ently extracted by two reviewers using electronic spread-
sheets until both parties agree that saturation has been
reached and no new outcomes are being found. A list of
outcomes will be compiled, and outcomes with different
verbatim terms but similar meaning combined in a sin-
gle term.
Consensus process
The COS will be developed by a consensus process in-
volving key stakeholders: namely, patients and members
of the public, dentists, clinical researchers, health econo-
mists, statisticians, policy-makers and industry represen-
tatives. Panelists will give their informed consent prior
to taking part in the consensus process. To increase up-
take of the resulting COS, we will engage with the
Cochrane Oral Health Group, clinical guideline devel-
opers, research funders, journal editors, regulators such
as research ethics committees, and trial registries.
We will attempt to ensure adequate representation
from each of the stakeholder groups to improve the
acceptance and implementation of the COS. No eth-
ical approval will be required for this study according
to the East of Scotland Research Ethics Service (reference
15/GA/0033).
We will attempt to gain consensus via a three-stage
Delphi process using an online platform to support a
specially designed e-Delphi portal. This has been
chosen as the most inclusive and pragmatic method to
include key stakeholders from different settings, back-
grounds and geographical locations. If consensus can-
not be reached on a full outcome set we will propose a
smaller core set based on those outcomes that have
agreement.
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For the first stage of the Delphi process, there will be
two panels created, a patient panel and a separate group
consisting of researchers, clinicians, teachers, industry
affiliated researchers, policy-makers, and other inter-
ested parties that are identified. The first round of the
Delphi process will be held separately for each of the
two panels and they will be combined in the later Delphi
stages. Recruitment of patient panelists and members of
the public will be performed within dental clinics (pa-
tients will be recruited from an existing pool in different
clinics) in different countries. An inclusive approach will
be taken aiming to involve patients from various socio-
economic and geographic backgrounds. An invitation
(plain language version sent where appropriate) with the
background of the COS development process will be
sent or given to potential panelists, providing them with
additional information regarding the practicalities of the
consensus process. Participants will be asked to reply to
the invitation using the e-Delphi portal, and, to
minimize attrition, only those accepting the invitation
and confirming active participation will be included in
the process. Panelists will be asked to review the list of
outcomes and add any that they consider relevant but
missing from the list. Panelists will be informed that a
minimum of two participants will have to propose an
outcome for it to be included in the next stage of the
process. The resulting list will again be harmonized
using this rule and with single terms being used for
items mentioned with multiple names. For this complete
list, panelists will then be asked to score each outcome
using the scale proposed by the GRADE group (http://
www.gradeworkinggroup.org), in which 1 to 3 signifies
an outcome of limited importance, 4 to 6 important but
not critical, and 7 to 9 critical.
The results from the two panels will be summarized
and fed back to individuals for the second round. In the
second round, the panels will be combined to give a sin-
gle panel and members will be reminded of their first
choice, and will be allowed to change their score in light
of the panel’s overall opinion. If there is a risk in the sec-
ond round of the patient voice not coming through we
will consider possible management options such as
weighting. As people who do not agree with the group
may be less inclined to continue the process, reminders
will be sent to participants who do not respond. This
should help to minimize overestimation of the extent of
the consensus.
Consensus that an outcome should be included in the
COS, will be defined as 70 % or more of the respondents
scoring it 7 to 9 and fewer than 15 % scoring it as 1 to 3
(e.g. outcome will be retained). Consensus that an out-
come should not be included in the COS will be defined
as 70 % or more scoring it as 1 to 3 and fewer than 15 %
scoring it as 7 to 9 (outcome will be discarded). If we
reach consensus on more than two and up to five items,
we will stop the consensus process and these items will
form the COS. If this is not achieved, the Delphi process
will be re-run.
Dissemination
To help increase the uptake of COS we will engage with
relevant groups such as the Cochrane Oral Health Group,
ORCA (the European Organization for Caries Research),
the International Association for Dental Research
Cariology Group, guideline development groups in-
cluding National Institute for Clinical Excellence, the Scottish
Intercollegiate Guideline Network and the Scottish Dental
Clinical Effectiveness Program, journal editors, trial regis-
tries and major funding bodies such as the UK National
Institute for Health Research (NIHR) Health Technology
Assessment or the German Research Foundation. An
overview of the trial can be found in Fig. 1.
Discussion
Both current research in dentistry (or more specifically
cariology) and its translation into clinical practice suffer
from the lack of agreed, defined, standardized and com-
parable trial outcomes. For example, the Cochrane Oral
Health Group database for reviews of “Dental caries
treatment,” contains 12 reviews. Eight of these reported
on less than two trials, whilst those four reviews that re-
ported on two or more trials all commented on the inad-
equacy of applied outcome measurements (“lack of
consistency” [7]; “insufficient outcome data on cost” [8];
“future research should investigate patient-centred out-
comes …. Health economic measures should be used to
determine the cost of treatment and patient willingness
to pay” [3]). Thus, there is a need to agree on a defined
set of minimum outcomes to be investigated and re-
ported in dental clinical trials. Increasing the compar-
ability between trials will allow more effective synthesis
of data, which in turn will strengthen the overall evi-
dence base and improve knowledge dissemination into
clinical practice.
Besides allowing comparison between, and synthesis
of, trials, defining and applying core outcomes might
eventually also improve dental and caries research, as
trialists will base their study evaluation on an agreed set
of outcomes and (in a second step) outcome measures.
Thus, future trial outcomes and results should be more
comprehensive and relevant to all stakeholders in the
field. To enhance this, we have built in broad stakeholder
and patient and public involvement in the process of de-
fining this COS. Using an agreed set of outcomes might,
therefore, lead to future trial designs being more rigorous,
transparent and accountable.
As described, involving stakeholders in the definition
of the COS on caries lesion management trials is planned
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and desirable. So far, only one COS has been defined in
dentistry using formal consensus methodology. This was
for pulp therapy in primary teeth, and did not include pa-
tients in the process [9]. One of the factors likely to com-
plicate the development of a COS for clinical trials of
interventions for dental caries will be the non-existence of
patient groups for dental caries (in contrast to other dis-
eases or conditions such as cancer or cleft lip/palate).
Thus, there is no option to approach a patient group dur-
ing the definition of the panel members. We plan to invite
patients from different clinical areas in dentistry; more-
over, the use of e-Delphi should also lower the barriers for
public and patient participation. From both a patient and
a clinician perspective, management of dental caries has a
number of situational-related influencing factors: for ex-
ample, payment systems, priorities (aesthetics versus
function) and differences placed on importance of the
dentition across countries. The inclusion of the public,
patients, researchers and other stakeholders from differ-
ent countries will facilitate inclusion of groups from di-
verse backgrounds to help include these variety factors.
Finally, some might find a COS for clinical trials to be
too rigid, restricting creative research. However, it will
be important to emphasize for those unfamiliar with
COS that the core outcomes are a minimum standard of
outcomes to be assessed and reported. Researchers will
be able to add other, specifically tailored outcomes to
their planned trial, or assess outcomes which are found
important after consulting patients or the wider public.
In this sense, this COS will need adaption and regular
updating as COS aim to reflect current agreed standards
on trial objectives and priorities.
In conclusion, there is great need for a COS for trials
on managing caries lesions. The planned development of
such a set will involve a range of stakeholders, especially
the public and patients. By using an explicit, transparent
multi-step consensus process, this COS will be justifi-
able, relevant and comprehensive. The dissemination
and application of this COS should improve clinical tri-
als on managing caries lesions and allow comparison,
synthesis and implementation of scientific data.
Trial status
The review stage of this trial is initiated, i.e. search strat-
egies have been developed and are currently being pilot-
tested.
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